| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: invention relates to 3-{4-[(2-{5-chloro-1-(diphenylmethyl)-2-[2-({[2-(trifluoromethyl)benzyl]sulphonyl} amino)ethyl]-1H-indol-3-yl}ethyl)sulphonyl]phenyl} propionic acid or pharmaceutically acceptable salt thereof, which inhibits cytoplasmic phospholipase A2 (cPLA2), which enables use thereof when treating asthma. ^ EFFECT: high efficiency of application. ^ 3 cl, 2 tbl, 5 dwg, 41 ex |
